Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...
Reexamination Certificate
2002-12-20
2010-11-16
Li, Q. Janice (Department: 1633)
Chemistry: molecular biology and microbiology
Maintaining blood or sperm in a physiologically active state...
C435S325000
Reexamination Certificate
active
07833697
ABSTRACT:
The present invention provides stem cells characterized as having the ability to renew and the ability to give rise to endothelial and/or endothelial-like cells, methods of isolating such stem cells and methods of use thereof. Also provided are progeny cells derived from the stem cells of the invention.
REFERENCES:
patent: 5980887 (1999-11-01), Isner et al.
patent: 6623940 (2003-09-01), Ledbetter et al.
patent: 6852537 (2005-02-01), Hebbel et al.
patent: 2005-514062 (2005-05-01), None
patent: WO 98/19712 (1998-05-01), None
patent: WO99/37751 (1999-07-01), None
patent: WO01/94420 (2001-12-01), None
patent: WO 03/060077 (2003-07-01), None
Mandel et al, Blood Nov. 2001;98(11-part2):55.
Schweitzer et al, Exp Hematol 1995;23:41-8.
Watt et al, Blood 2000;95:3113-24.
Clancy et al., Arthrit Rheumat 2001;44 :1203-8.
Solovey et al, NEJM 1997;337:1584-90.
Gupta et al, Exp Cell Res 1997;230:244.
Domotor et al, Neurochem Int. 1998;33(6):473-8.
Walenta et al. Biochem Biophy Res Comm 2005;333:476-82.
Delorme et al. Thromb Haemost 2005;94:1270-9.
Martin-Padura et al. Curr Pharm Design 2008;14:3780-9.
Bossuyt et al. Cytometry 1997;30:124-33.
Pulido et al. J Immunol 1998;140:3851-7.
Strijbos et al. Brit J Cancer 2008;98:1731-5.
Bhatia et al., “AC133 expression in stem cells,”Leukemia 15:1685-1688, 2001.
Filshie et al., “MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies,”Leukemia 12:414-421, 1998.
Ikpeazu et al., “Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation,”Bio Blood Marrow Transplant 6:301-308, 2000.
Leukocyte Typing VII, Mason et al. (ed.s), Oxford University Press, 2002, pp. 344-346.
Quirici et al., “Differentiation and expansion of endothelial cells from human bone marrow CD133+cells,”Brit J Haematl 115:186-194, 2001.
Solovey et al., “Identification and functional assessment of endothelial P1 H12,”J Lab Clin Med 138322-331, 2001.
Spangrude et al., “Resting and activated subsets of mouse multipotent hematopoietic stem cells,”Proc Natl Acad Sci USA 87:7433-7437, 1990.
Wiley et al., “A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis,”Immunity 15:837-846, 2001.
Woywodt et al., “Detection of circulating endothelial cells,”DYNALogue 2:20-21, 2003.
International Search Report, PCT/US02/41161, mailed Nov. 12, 2003.
Asahara et al., “Isolation of Putative Progenitor Endothelial Cells for Angiogenesis,”Science 275:964-967, 1997.
Gehling et al., “In vitro differentiation of endothelial cells from AC133-positive progenitor cells,”Blood 95(10):3106-3112, 2000.
Gill et al, “Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+Endothelial Precursor Cells,”Circ. Res. 88:167-174, 2001.
Huss, “Isolation of Primary and Immortalized CD34−Hematopoietic and Mesenchymal Stem Cells from Various Sources,”Stem Cells 18:1-9, 2000.
Kalka et al, “Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization,”Proc. Natl. Acad. Sci. USA 97(7):3422-3427, 2000.
Kawamoto et al., “Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia,”Circulation 103:634-637, 2001.
Peichev et al., “Expression of VEGFR-2 and AC133 by circulating human CD34+cells identified a population of functional endothelial precursors,”Blood 95(3):952-958, 2000.
Qun Shi et al., “Evidence for Circulating Bone Marrow-Derived Endothelial Cells,”Blood 92:362-367, 1998.
St. Croix et al., “Genes Expressed in Human Tumor Endothelium,”Science 289:1197-1202, 2000.
European Exam Report, Application No. 02796023.6 (PCT/US0241161), Jan. 16, 2006.
Burger P.E., et al., “Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells,”Blood100(10):3527-3535, 2002.
Almeida-Porada G. and Ascensao J. L. “Isolation, characterization, and biologic features of bone marrow endothelial cells,”Journal of Laboratory and Clinical Medicine128 (4):399-407,1996.
Ito H., et al., “Endothelial Progenitor Cells as Putative Targets for Angiostatin,”Cancer Research 59:5875-5877, 1999.
Gronthos et al. “Surface Protein Characterization of Human Adipose Tissue-Derived Stromal Cells”.J. Cell. Physiol. 189: 54-63 (20001).
Mehra et al. “Progenitor Marker CD133 mRNA Is Elevatied in Peripheral Blood of Cancer Patients with Bone Metastases.”Clin. Cancer Res. 12(16):4859-4866 (2006).
Vainlo et al. “HEMCAM, an Adhesion Molecule Expressed by c-Kit Hemopoietic Progenitors”J. Cell Biol. 135(6):1655-1668 (1996).
Balconi, G. et al., Arterioscler. Thromb, Vasc. Biol. 2000, 20:1443-1451.
Daniel Thomas O.
Fanslow, III William C.
Rousseau Anne-Marie C.
Immunex Corporation
Li Q. Janice
Machin Nathan A.
LandOfFree
Endothelial stem cells, populations, methods of isolation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endothelial stem cells, populations, methods of isolation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelial stem cells, populations, methods of isolation... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4174423